stock
MPLT · MapLight Therapeutics, Inc.
What MapLight Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live MPLT price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on MPLT.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 42,436,326 as of 2026-03-19 (XBRL frame CY2026Q1I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -66.0%
- ROA
- -62.4%
Health
- Current ratio
- 16.5x
- Debt/equity
- —
Deep value
- NCAV
- $298.74M
- NCAV per share
- $7.04
- Price/NCAV
- Locked
- NNWC
- $51.58M
- NNWC per share
- $1.22
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$63.55M | -$60.19M | 10-Q filed 2026-08-13 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$64.50M | -$60.67M | 10-Q filed 2026-08-13 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$83.38M | -$79.55M | 10-K filed 2026-03-26 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$31.50M | -$29.42M | 10-Q filed 2025-12-04 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$30.66M | -$29.84M | 10-Q filed 2026-08-13 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$23.54M | -$22.34M | 10-Q filed 2026-08-13 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | — | -$21.23M | 10-K filed 2026-03-26 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$20.89M | -$19.02M | 10-Q filed 2025-12-04 |
- Assets
- $368.35M
- Equity
- $348.30M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$169.08M | -$161.15M | -$138.61M |
| 2024-12-31 | — | -$82.95M | -$77.58M | -$79.58M |
Company filings
2 offering filings in 12 months
events
Material agreement, Results, Unregistered share sale, Regulation FD disclosure
Material agreementResultsUnregistered share saleRegulation FD disclosureAug 138-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventJul 278-KShareholder vote results
Shareholder vote resultsJun 248-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventJun 228-KExecutive or director change
Executive or director changeJun 188-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureMay 148-K
5% owners ()
Nan Fung Group Holdings Limited
Passive stake
Catalyst4, Inc.
Stake update
Catalyst4, Inc.
Stake update
Novo Holdings A/S
Stake update
T. Rowe Price Investment Management, Inc.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Hanson Kristopher
General Counsel
Sale$192,660Sep 18, 4:15 PM ET
Lillie James Woodruff
Chief Scientific Officer
Sale$276,908Aug 4, 8:39 PM ET
Cox Troy
Director
Buy$148,702Jul 28, 9:14 PM ET
GILLIS JONATHAN
CAO and Interim CFO
Sale$1,372,668Jul 20, 6:00 AM ET
Kreitzer Anatol
Chief Discovery Officer
Sale$1,345,894Jul 20, 6:00 AM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named MPLT, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about MPLT.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on MPLT come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the MPLT board